• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Hyperion Therapeutics Inc

+ Add to Watchlist

0HY:GR

18.554 EUR 0.302 1.65%

As of 10:29:49 ET on 12/22/2014.

Snapshot for Hyperion Therapeutics Inc (0HY)

Open: 18.381 Day's Range: 18.327 - 18.554 Volume: 0
Previous Close: 18.252 52wk Range: 14.415 - 23.614 1-Yr Rtn: +19.49%

Stock Chart for 0HY

No chart data available.
  • 0HY:GR 18.381
  • 1D
  • 1M
  • 1Y
18.252
Interactive 0HY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 0HY

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.9430
Est. PEG Ratio -
Market Cap (M EUR) 384.50
Shares Outstanding (M) 20.72
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 0HY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 0HY

Hyperion Therapeutics Inc. operates as a biopharmaceutical company. The Company develops therapeutics to treat disorders in the areas of orphan diseases and hepatology. Hyperion Therapeutics offers its services throughout the United States.

James I Healy "Jim"ChairmanDonald J SantelChief Executive Officer
Jeffrey S FarrowChief Financial OfficerBruce F ScharschmidtSenior VP
More Company Profile & Key Executives for 0HY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil